HCA Holdings (NYSE: HCA) reported Q3 EPS of $1.21, $0.72 worse than the analyst estimate of $1.93. Revenue for the quarter came in at $10.7 billion versus the consensus estimate of $11.13 billion.

Key third quarter metrics (all percentage changes compare 3Q 2017 to 3Q 2016 unless noted):

• Revenues increased 4.2 percent to $10.696 billion
• Net income attributable to HCA Healthcare, Inc. totaled $426 million, or $1.15 per diluted share
• Adjusted EBITDA totaled $1.776 billion
• Cash flows from operations totaled $1.008 billion
• Same facility equivalent admissions increased 0.3 percent, while same facility admissions increased 0.6 percent
• Same facility revenue per equivalent admission increased 2.0 percent
• Same facility emergency room visits increased 0.3 percent

GUIDANCE:

HCA Holdings sees FY 2017 EPS of $6.45-$6.70, versus the consensus of $6.77. HCA Holdings sees FY 2017 revenue of $43-44 billion, versus the consensus of $43.18 billion.

The Company’s 2017 updated guidance contains a number of assumptions, including:

• 2017 guidance for EPS (diluted) includes an estimated $90 million income tax benefit, or $0.24 per diluted share, related to the accounting standard which requires the recording of excess tax benefits related to employee equity award settlements as a component of the provision for income taxes. The timing and amounts related to employee equity award settlements are difficult to project and may vary from this estimate.
• 2017 guidance includes expected full-year earnings for the Company’s Oklahoma facilities which are under agreement to be sold. The Company now estimates a closing date of December 31, 2017.
• 2017 guidance includes the impact of acquisitions completed as of September 30, 2017.
• 2017 guidance excludes the impact of items such as, but not limited to, gains or losses on sales of facilities, losses on retirement of debt, legal claim costs and impairments of long-lived assets.

For earnings history and earnings-related data on HCA Holdings (HCA) click here.